BCR-DLBCL (U2932) cells reached a maximal incorporation of d-[U-13C]-glucose into citrate of only 15%, which was also decreased by MPC inhibition, although this change was not statistically significant (Fig. 1D). This evidence concerns the gene BCR and diffuse large B-cell lymphoma.